Embolic devices

US10124090B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10124090-B2
Application numberUS-201514678525-A
CountryUS
Kind codeB2
Filing dateApr 3, 2015
Priority dateApr 3, 2014
Publication dateNov 13, 2018
Grant dateNov 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are apparatus, compositions, systems and methods for occluding vascular structures and vascular malformations with radiopaque hydrogel filaments. The filaments can contain no support members and can be CT and MR compatible. Methods of forming such filaments are also disclosed.

First claim

Opening claim text (preview).

We claim: 1. An implantable coil comprising: a shapeable polymeric filament formed from a combination of precursors comprising a trimethylolpropane ethoxylate triacrylamide macromer; t-butyl acrylamide monomer and a hydroxyethyl methacrylate monomer; and a crosslinker; and comprising at least one visualization agent; and an overcoil wrapped multiple times around at least a portion of the shapeable polymeric filament, the overcoil configured to create contact area spacing between the filament and a delivery catheter. 2. The implantable coil according to claim 1 , having reduced beam hardening artifacts when imaged using computed tomography. 3. The implantable coil according to claim 1 , wherein the at least one visualization agent is selected from metallic powders, gadolinium, superparamagnetic iron oxide particles, barium sulfate or a combination thereof. 4. The implantable coil according to claim 1 , wherein the polymeric filament has a diameter of less than about 0.03 inches. 5. The implantable coil according to claim 1 , wherein the polymeric filament is non-resorbable by body tissues. 6. The implantable coil according to claim 1 , wherein the polymeric filament is biodegradable. 7. The implantable coil according to claim 1 , wherein the trimethylolpropane ethoxylate triacrylamide macromer is trimethylolpropane ethoxylate triacrylamide having a molecular weight of 900 g/mol. 8. The implantable coil according to claim 1 , wherein the cross-linker is N,N′-methylenebisacrylamide. 9. An implantable coil including: a hydrogel filament consisting essentially of about 27% w/w trimethylolpropane ethoxylate triacrylamide 900, about 6% w/w t-butyl acrylamide, about 2% hydroxyethyl methacrylate, about 0.5% w/w N,N-methylenebisacrylamide, about 64% barium sulfate, and about 0.5% 2,2′-azobisisobutyronitrile, and an overcoil wrapped multiple times around at least a portion of the filament, the overcoil configured to create contact area spacing between the filament and a delivery catheter. 10. An implantable coil including: a hydrogel filament consisting essentially of about 30% w/w trimethylolpropane ethoxylate triacrylamide 900, about 6% w/w t-butyl acrylamide, about 2% hydroxyethyl methacrylate, about 0.75% w/w N,N-methylenebisacrylamide, about 48% barium sulfate, and about 0.5% 2,2′-azobisisobutyronitrile, and an overcoil wrapped multiple times around at least a portion of the filament, the overcoil configured to create contact area spacing between the filament and a delivery catheter. 11. The implantable coil according to claim 1 , wherein the overcoil is formed of a polymeric material or a metallic material. 12. The implantable coil according to claim 11 , wherein the polymeric material includes nylon, PEEK, PTFE, EPTFE, or a combination thereof, or wherein the metallic material includes stainless steel, nitinol, cobalt, chromium, tantalum, gold, platinum, barium, or a combination thereof.

Assignees

Inventors

Classifications

  • A61L31/048Primary

    obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence) · CPC title

  • Materials at least partially X-ray or laser opaque · CPC title

  • Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates · CPC title

  • for embolization or occlusion, e.g. vaso-occlusive compositions or devices · CPC title

  • Hydrogels or hydrocolloids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10124090B2 cover?
Described herein are apparatus, compositions, systems and methods for occluding vascular structures and vascular malformations with radiopaque hydrogel filaments. The filaments can contain no support members and can be CT and MR compatible. Methods of forming such filaments are also disclosed.
Who is the assignee on this patent?
Microvention Inc, Terumo Corp
What technology area does this patent fall under?
Primary CPC classification A61L31/048. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).